z-logo
open-access-imgOpen Access
Identification of MOAG-4/SERF as a Regulator of Age-Related Proteotoxicity
Author(s) -
Tjakko J. van Ham,
M. Holmberg,
Annemieke T. van der Goot,
Eva Teuling,
Moisés Garcı́a-Arencibia,
Hyun-Eui Kim,
Deguo Du,
Karen L. Thijssen,
Marit Wiersma,
Rogier C Burggraaff,
Petra van Bergeijk,
Jeroen van Rheenen,
G. Jerre van Veluw,
Robert M.W. Hofstra,
David C. Rubinsztein,
Ellen A. A. Nollen
Publication year - 2010
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2010.07.020
Subject(s) - proteotoxicity , biology , protein aggregation , regulator , alpha synuclein , amyloid (mycology) , microbiology and biotechnology , autophagy , caenorhabditis elegans , disease , genetics , parkinson's disease , gene , medicine , apoptosis , botany
Fibrillar protein aggregates are the major pathological hallmark of several incurable, age-related, neurodegenerative disorders. These aggregates typically contain aggregation-prone pathogenic proteins, such as amyloid-beta in Alzheimer's disease and alpha-synuclein in Parkinson's disease. It is, however, poorly understood how these aggregates are formed during cellular aging. Here we identify an evolutionarily highly conserved modifier of aggregation, MOAG-4, as a positive regulator of aggregate formation in C. elegans models for polyglutamine diseases. Inactivation of MOAG-4 suppresses the formation of compact polyglutamine aggregation intermediates that are required for aggregate formation. The role of MOAG-4 in driving aggregation extends to amyloid-beta and alpha-synuclein and is evolutionarily conserved in its human orthologs SERF1A and SERF2. MOAG-4/SERF appears to act independently from HSF-1-induced molecular chaperones, proteasomal degradation, and autophagy. Our results suggest that MOAG-4/SERF regulates age-related proteotoxicity through a previously unexplored pathway, which will open up new avenues for research on age-related, neurodegenerative diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom